Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2004-12-08
2008-10-14
Gambel, Phillip (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S387300, C530S388730, C530S388220
Reexamination Certificate
active
07435802
ABSTRACT:
The invention provides methods of treatment using humanized immunoglobulins that specifically bind to alpha-4 integrin. The methods are useful for treatment of asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, and acute leukocyte mediated lung injury.
REFERENCES:
patent: 5840299 (1998-11-01), Bendig et al.
Bendig Mary M.
Jones Tarran S.
Leger Olivier J.
Saldanha Jose
Yednock Ted A.
Crowell & Moring LLP
Elan Pharaceuticals, Inc.
Gambel Phillip
LandOfFree
Humanized anti-VLA4 immunoglobulins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Humanized anti-VLA4 immunoglobulins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Humanized anti-VLA4 immunoglobulins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3999638